Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kassiou

Showing results (11-20 of 231) with videos related to

Pageof 24
Sort By:
Current Medicinal Chemistry|June 23, 2007
Molecular probes for P2X7 receptor studiesHendra Gunosewoyo, Mark J Coster, Michael Kassiou
Chemical Reviews|July 2, 2011
Boron in drug discovery: carboranes as unique pharmacophores in biologically active compoundsFatiah Issa, Michael Kassiou, Louis M Rendina
Journal of Labelled Compounds & Radiopharmaceuticals|November 29, 2013
The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET)Samuel D Banister, Miral Manoli, Michael Kassiou
European Journal of Medicinal Chemistry|April 8, 2025
The adamantane scaffold: Beyond a lipophilic moietyChianna Dane, Andrew P Montgomery, Michael Kassiou
Biochemical Society Transactions|November 10, 2015
TSPO as a target for glioblastoma therapeuticsEryn L Werry, Melissa L Barron, Michael Kassiou
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (σ2) receptor ligandsSamuel D Banister, Louis M Rendina, Michael Kassiou
Current Medicinal Chemistry|August 20, 2009
Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomographyFrédéric Dollé, Christopher Luus, Aaron Reynolds, et al.
Expert Review of Neurotherapeutics|March 15, 2014
The translocator protein as a drug target in Alzheimer's diseaseSook W Chua, Michael Kassiou, Lars M Ittner
Brain Research. Brain Research Reviews|April 27, 2005
Ligands for peripheral benzodiazepine binding sites in glial cellsMichael Kassiou, Steven R Meikle, Richard B Banati
Future Medicinal Chemistry|February 9, 2017
Kinase targets in CNS drug discoveryHendra Gunosewoyo, Lifang Yu, Lenka Munoz, et al.
Pageof 24

Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
Current Medicinal Chemistry|June 23, 2007
Molecular probes for P2X7 receptor studiesHendra Gunosewoyo, Mark J Coster, Michael Kassiou
Chemical Reviews|July 2, 2011
Boron in drug discovery: carboranes as unique pharmacophores in biologically active compoundsFatiah Issa, Michael Kassiou, Louis M Rendina
Journal of Labelled Compounds & Radiopharmaceuticals|November 29, 2013
The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET)Samuel D Banister, Miral Manoli, Michael Kassiou
European Journal of Medicinal Chemistry|April 8, 2025
The adamantane scaffold: Beyond a lipophilic moietyChianna Dane, Andrew P Montgomery, Michael Kassiou
Biochemical Society Transactions|November 10, 2015
TSPO as a target for glioblastoma therapeuticsEryn L Werry, Melissa L Barron, Michael Kassiou
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (σ2) receptor ligandsSamuel D Banister, Louis M Rendina, Michael Kassiou
Current Medicinal Chemistry|August 20, 2009
Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomographyFrédéric Dollé, Christopher Luus, Aaron Reynolds, et al.
Expert Review of Neurotherapeutics|March 15, 2014
The translocator protein as a drug target in Alzheimer's diseaseSook W Chua, Michael Kassiou, Lars M Ittner
Brain Research. Brain Research Reviews|April 27, 2005
Ligands for peripheral benzodiazepine binding sites in glial cellsMichael Kassiou, Steven R Meikle, Richard B Banati
Future Medicinal Chemistry|February 9, 2017
Kinase targets in CNS drug discoveryHendra Gunosewoyo, Lifang Yu, Lenka Munoz, et al.
Pageof 24